SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 132 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,056,000 | +1.4% | 94,464 | -0.1% | 0.00% | 0.0% |
| Q2 2017 | $1,041,000 | +28.7% | 94,599 | +14.4% | 0.00% | 0.0% |
| Q1 2017 | $809,000 | -9.6% | 82,667 | -0.3% | 0.00% | 0.0% |
| Q4 2016 | $895,000 | +102.9% | 82,891 | +91.4% | 0.00% | – |
| Q3 2016 | $441,000 | +293.8% | 43,314 | +400.2% | 0.00% | – |
| Q2 2016 | $112,000 | +23.1% | 8,660 | 0.0% | 0.00% | – |
| Q1 2016 | $91,000 | +9.6% | 8,660 | -4.9% | 0.00% | – |
| Q4 2015 | $83,000 | +31.7% | 9,102 | 0.0% | 0.00% | – |
| Q3 2015 | $63,000 | -26.7% | 9,102 | 0.0% | 0.00% | – |
| Q2 2015 | $86,000 | +7.5% | 9,102 | 0.0% | 0.00% | – |
| Q1 2015 | $80,000 | 0.0% | 9,102 | 0.0% | 0.00% | – |
| Q4 2014 | $80,000 | +19.4% | 9,102 | -6.3% | 0.00% | – |
| Q3 2014 | $67,000 | – | 9,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |